CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19

NCT04516941 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
60
Enrollment
OTHER
Sponsor class

Stopped Insufficient rate of patient accrual and newly available scientific evidence

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators